The role of infection in the pathogenesis of idiopathic pulmonary fibrosis
- PMID: 23997064
- PMCID: PMC9487348
- DOI: 10.1183/09059180.00000713
The role of infection in the pathogenesis of idiopathic pulmonary fibrosis
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive, and invariably fatal, condition that is believed to arise in genetically susceptible individuals as a consequence of an aberrant wound-healing response following repetitive alveolar injury. The exact triggers, which initiate the fibrotic process, remain unknown. Infectious agents, including both viruses and bacteria, have the capacity to cause alveolar-epithelial cell injury and apoptosis. Relatively few studies have examined the role of infection in IPF. Those that have, point to viruses playing a key role as cofactors in the initiation and progression of IPF. There is also some evidence to suggest that viral infection may be responsible for a proportion of acute exacerbations of IPF. The role played by bacteria in the pathogenesis of IPF is less clear cut. Studies from other respiratory diseases suggest that alterations in the lung microbiome are associated with disease and that these changes influence disease behaviour. Emerging molecular microbiological techniques are making the study of microbial communities in the lung easier. It is hoped that by combining such techniques with the careful longitudinal phenotyping of patients with IPF, it will be possible to elucidate the role played by bacteria and viruses in the pathogenesis of the disease. If infection plays a causal role in IPF then it is possible that therapeutic strategies, utilising currently available antiviral or antibiotic drugs, may be effective in modifying the course of this devastating condition.
Conflict of interest statement
Conflict of interest: None declared.
Similar articles
-
The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis.Eur Respir Rev. 2019 Jul 8;28(152):190045. doi: 10.1183/16000617.0045-2019. Print 2019 Jun 30. Eur Respir Rev. 2019. PMID: 31285290 Free PMC article. Review.
-
Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.Ann Am Thorac Soc. 2015 Nov;12 Suppl 2(Suppl 2):S186-92. doi: 10.1513/AnnalsATS.201502-088AW. Ann Am Thorac Soc. 2015. PMID: 26595738 Free PMC article. Review.
-
Bacterial and viral coinfection in idiopathic pulmonary fibrosis patients: the prevalence and possible role in disease progression.BMC Pulm Med. 2022 Feb 11;22(1):60. doi: 10.1186/s12890-022-01853-y. BMC Pulm Med. 2022. PMID: 35148733 Free PMC article.
-
Viral infection and aging as cofactors for the development of pulmonary fibrosis.Expert Rev Respir Med. 2010 Dec;4(6):759-71. doi: 10.1586/ers.10.73. Expert Rev Respir Med. 2010. PMID: 21128751 Free PMC article. Review.
-
Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy.Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6379-6386. doi: 10.26355/eurrev_201907_18463. Eur Rev Med Pharmacol Sci. 2019. PMID: 31364146 Review.
Cited by
-
COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.Immunol Rev. 2021 Jul;302(1):228-240. doi: 10.1111/imr.12977. Epub 2021 May 24. Immunol Rev. 2021. PMID: 34028807 Free PMC article. Review.
-
Effects of smoking on the lower respiratory tract microbiome in mice.Respir Res. 2018 Dec 14;19(1):253. doi: 10.1186/s12931-018-0959-9. Respir Res. 2018. PMID: 30547792 Free PMC article.
-
No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients.Respir Res. 2023 Mar 20;24(1):87. doi: 10.1186/s12931-023-02396-4. Respir Res. 2023. PMID: 36941652 Free PMC article.
-
The lung microbiome: clinical and therapeutic implications.Intern Emerg Med. 2019 Nov;14(8):1241-1250. doi: 10.1007/s11739-019-02208-y. Epub 2019 Oct 31. Intern Emerg Med. 2019. PMID: 31667699 Review.
-
Impact of Respiratory Bacterial Findings on Patients with Chronic Pulmonary Aspergillosis.Int J Microbiol. 2024 Apr 30;2024:1329884. doi: 10.1155/2024/1329884. eCollection 2024. Int J Microbiol. 2024. PMID: 38716459 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical